AcelRx Pharmaceuticals(ACRX) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025, were $9.8 million Three new clinical study sites activated and screening patients thus far in 2025, with five additional sites expected by mid-year, for a total of 13 Conference call and webcast to be held Wednesday, May 14, 2025 at 4:30 pm ET SAN ...